Literature DB >> 9043024

A follow-up study of progression from dysplasia to squamous cell carcinoma with immunohistochemical examination of p53 protein overexpression in the bronchi of ex-chromate workers.

Y Satoh1, Y Ishikawa, K Nakagawa, T Hirano, E Tsuchiya.   

Abstract

Squamous cell carcinoma (SCC) of the bronchus is considered to develop from preneoplastic 'dysplasia', but reports of sequential observation of this dysplasia-carcinoma sequence in humans are very few. We followed four dysplastic lesions found in the bronchi of three ex-chromate workers by bronchoscopy and biopsy and found that all of them progressed to SCC. Of the four lesions, three were severe dysplasias at the first biopsy which progressed to SCCs in 7-13 months. The last one was a slight dysplasia at the first biopsy and showed progression of the atypia to carcinoma in 6 years and 10 months. An immunohistochemical analysis of the chronological change in p53 protein expression in these lesions and in normal ciliated epithelium taken from the surroundings was conducted in each case. Overexpression of p53 protein was observed in two of the severe dysplasias and the one slight dysplasia, as well as their eventual SCCs. However, no such change was apparent in one case of severe dysplasia or its eventual SCC. Normal epithelium was consistently negative. Our results provide direct proof of the dysplasia-carcinoma sequence and suggest that alteration in the expression of p53 protein might be an important early event which persists. Therefore, the immunohistochemical detection of p53 overexpression in biopsy specimens of bronchial epithelium might be useful for evaluation of preneoplastic lesions in high-risk group individuals and for early diagnosis of bronchial cancer.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9043024      PMCID: PMC2063337          DOI: 10.1038/bjc.1997.121

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  12 in total

1.  Deletions of 17p and p53 mutations in preneoplastic lesions of the lung.

Authors:  G Sozzi; M Miozzo; R Donghi; S Pilotti; C T Cariani; U Pastorino; G Della Porta; M A Pierotti
Journal:  Cancer Res       Date:  1992-11-01       Impact factor: 12.701

2.  DURATION OF BRONCHIAL SQUAMOUS METAPLASIA PRODUCED IN DOGS BY CIGARETTE SMOKE CONDENSATE.

Authors:  D L TIPTON; T T CROCKER
Journal:  J Natl Cancer Inst       Date:  1964-09       Impact factor: 13.506

3.  Cancer. A deadly inheritance.

Authors:  B Vogelstein
Journal:  Nature       Date:  1990 Dec 20-27       Impact factor: 49.962

4.  Development of carcinoma of the lung as reflected in exfoliated cells.

Authors:  G Saccomanno; V E Archer; O Auerbach; R P Saunders; L M Brennan
Journal:  Cancer       Date:  1974-01       Impact factor: 6.860

5.  p53 protein accumulates frequently in early bronchial neoplasia.

Authors:  W P Bennett; T V Colby; W D Travis; A Borkowski; R T Jones; D P Lane; R A Metcalf; J M Samet; Y Takeshima; J R Gu
Journal:  Cancer Res       Date:  1993-10-15       Impact factor: 12.701

6.  p53 and chromosome 3 abnormalities, characteristic of malignant lung tumours, are detectable in preinvasive lesions of the bronchus.

Authors:  V Sundaresan; P Ganly; P Hasleton; R Rudd; G Sinha; N M Bleehen; P Rabbitts
Journal:  Oncogene       Date:  1992-10       Impact factor: 9.867

7.  Evidence of cumulative gene losses with progression of premalignant epithelial lesions to carcinoma of the bronchus.

Authors:  L Thiberville; P Payne; J Vielkinds; J LeRiche; D Horsman; G Nouvet; B Palcic; S Lam
Journal:  Cancer Res       Date:  1995-11-15       Impact factor: 12.701

8.  Squamous metaplasia expression of proto-oncogenes and P 53 in lung cancer patients.

Authors:  N Klein; J M Vignaud; M Sadmi; F Plenat; J Borelly; A Duprez; Y Martinet; N Martinet
Journal:  Lab Invest       Date:  1993-01       Impact factor: 5.662

Review 9.  Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.

Authors:  M S Greenblatt; W P Bennett; M Hollstein; C C Harris
Journal:  Cancer Res       Date:  1994-09-15       Impact factor: 12.701

10.  Characteristics of chromate workers' cancers, chromium lung deposition and precancerous bronchial lesions: an autopsy study.

Authors:  Y Ishikawa; K Nakagawa; Y Satoh; T Kitagawa; H Sugano; T Hirano; E Tsuchiya
Journal:  Br J Cancer       Date:  1994-07       Impact factor: 7.640

View more
  7 in total

Review 1.  Lung cancer . 3: Fluorescence bronchoscopy: clinical dilemmas and research opportunities.

Authors:  A K Banerjee; P H Rabbitts; J George
Journal:  Thorax       Date:  2003-03       Impact factor: 9.139

Review 2.  Natural history of bronchial preinvasive lesions.

Authors:  Taichiro Ishizumi; Annette McWilliams; Calum MacAulay; Adi Gazdar; Stephen Lam
Journal:  Cancer Metastasis Rev       Date:  2010-03       Impact factor: 9.264

3.  EGFR/erB-1, HER2/erB-2, CK7, LP34, Ki67 and P53 expression in preneoplastic lesions of bronchial epithelium: an immunohistochemical and genetic study.

Authors:  Vítor Sousa; Joana Espírito Santo; Maria Silva; Teresa Cabral; Ana Maria Alarcão; Ana Gomes; Patrícia Couceiro; Lina Carvalho
Journal:  Virchows Arch       Date:  2011-03-22       Impact factor: 4.064

4.  Detection and minimally invasive treatment of early squamous lung cancer.

Authors:  Johannes M A Daniels; Thomas G Sutedja
Journal:  Ther Adv Med Oncol       Date:  2013-07       Impact factor: 8.168

Review 5.  Genetic and epigenetic mechanisms in metal carcinogenesis and cocarcinogenesis: nickel, arsenic, and chromium.

Authors:  Konstantin Salnikow; Anatoly Zhitkovich
Journal:  Chem Res Toxicol       Date:  2007-10-30       Impact factor: 3.739

6.  p53 activation by Cr(VI): a transcriptionally limited response induced by ATR kinase in S-phase.

Authors:  Michal W Luczak; Casey Krawic; Anatoly Zhitkovich
Journal:  Toxicol Sci       Date:  2019-08-06       Impact factor: 4.849

7.  Toxicological Antagonism among Welding Fume Metals: Inactivation of Soluble Cr(VI) by Iron.

Authors:  Casey Krawic; Anatoly Zhitkovich
Journal:  Chem Res Toxicol       Date:  2018-11-06       Impact factor: 3.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.